164 related articles for article (PubMed ID: 36282576)
1. A preventable, life-altering case of fluoroquinolone-associated tendonitis.
Wildermuth A; Holmes M
JAAPA; 2022 Nov; 35(11):33-36. PubMed ID: 36282576
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?
Bidell MR; Lodise TP
Pharmacotherapy; 2016 Jun; 36(6):679-93. PubMed ID: 27138564
[TBL] [Abstract][Full Text] [Related]
3. [Fluoroquinolone-induced tendon diseases].
Medrano San Ildefonso M; Mauri Llerda JA; Bruscas Izu C
An Med Interna; 2007 May; 24(5):227-30. PubMed ID: 17907887
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolone-associated tendinopathy.
Tsai WC; Yang YM
Chang Gung Med J; 2011; 34(5):461-7. PubMed ID: 22035890
[TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolone-mediated Achilles rupture: a case report and review of the literature.
Budny AM; Ley AN
J Foot Ankle Surg; 2015; 54(3):494-6. PubMed ID: 25451202
[TBL] [Abstract][Full Text] [Related]
6. Fluoroquinolone-Associated Tendinopathy of the Hand and Wrist: A Systematic Review and Case Report.
Berger I; Goodwin I; Buncke GM
Hand (N Y); 2017 Sep; 12(5):NP121-NP126. PubMed ID: 28366020
[TBL] [Abstract][Full Text] [Related]
7. Association between oral fluoroquinolone use and lateral canthal tendon rupture: case report.
Alhabshan RN; Mansour TN
Orbit; 2018 Oct; 37(5):358-360. PubMed ID: 29303391
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolones and tendinopathy: a guide for athletes and sports clinicians and a systematic review of the literature.
Lewis T; Cook J
J Athl Train; 2014; 49(3):422-7. PubMed ID: 24762232
[TBL] [Abstract][Full Text] [Related]
9. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
Martin SJ; Jung R; Garvin CG
Drug Saf; 2001; 24(3):199-222. PubMed ID: 11347723
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone-induced Achilles tendinitis.
Tam PK; Ho CT
Hong Kong Med J; 2014 Dec; 20(6):545-7. PubMed ID: 25488035
[TBL] [Abstract][Full Text] [Related]
11. Triceps Ruptures After Fluoroquinolone Antibiotics: A Report of 2 Cases.
Shybut TB; Puckett ER
Sports Health; 2017; 9(5):474-476. PubMed ID: 28610536
[TBL] [Abstract][Full Text] [Related]
12. A rare but a serious complication: gemifloxacin induced tendinopathy.
Kanbay A; Mıhcıoğlu İ; Tekin N
Tuberk Toraks; 2020 Jul; 68(2):184-187. PubMed ID: 32755119
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency.
Bennett AC; Bennett CL; Witherspoon BJ; Knopf KB
Expert Opin Drug Saf; 2019 Nov; 18(11):1055-1063. PubMed ID: 31500468
[No Abstract] [Full Text] [Related]
14. US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions.
Jones SC; Budnitz DS; Sorbello A; Mehta H
Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1099-106. PubMed ID: 23963962
[TBL] [Abstract][Full Text] [Related]
15. An elderly patient with fluoroquinolone-associated achilles tendinitis.
Damuth E; Heidelbaugh J; Malani PN; Cinti SK
Am J Geriatr Pharmacother; 2008 Dec; 6(5):264-8. PubMed ID: 19161929
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone-associated tendinopathy: a critical review of the literature.
Khaliq Y; Zhanel GG
Clin Infect Dis; 2003 Jun; 36(11):1404-10. PubMed ID: 12766835
[TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin-induced tendinopathy of the gluteal tendons.
Shimatsu K; Subramaniam S; Sim H; Aronowitz P
J Gen Intern Med; 2014 Nov; 29(11):1559-62. PubMed ID: 25047394
[TBL] [Abstract][Full Text] [Related]
18. Levofloxacin-induced bilateral Achilles tendonitis.
Lewis JR; Gums JG; Dickensheets DL
Ann Pharmacother; 1999; 33(7-8):792-5. PubMed ID: 10466906
[TBL] [Abstract][Full Text] [Related]
19. Moxifloxacin: new preparation. A me-too with more cardiac risks.
Prescrire Int; 2002 Dec; 11(62):168-9. PubMed ID: 12469694
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
Hansen GT; Blondeau JM
J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
